Open House biologics rebate contracts 2026 - 29 rituximab (finished medicinal products only)
Techniker Krankenkasse, HamburgTED 707429-2026
value not stated1 lot
Thu 30 Nov23:58 in Berlin
763days
Medical supplies contracts
4,346 open tenders
Email me new onesCountryTenderValueClosesDays left
Open-house discount agreements 2026-18
Techniker Krankenkasse, HamburgTED 742945-2026
value not stated10 lots
Thu 30 Nov23:58 in Berlin
763days
Conclusion of a non-exclusive pharmaceutical discount agreement pursuant to § 130a para. 8 SGB V under an open-house model for the active substance Apixaban (WHO ATC Code: B01AF02)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 672860-2026
value not stated1 lot
Thu 30 Nov23:58 in Berlin
763days
Conclusion of a non-exclusive medicinal product discount agreement pursuant to Section 130a Paragraph 8 of the Fifth Book of the German Social Code (SGB V) under an open-house model for the active substance Pancreatin (WHO ATC Code: A09AA02)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 718722-2026
value not stated1 lot
Thu 30 Nov23:58 in Berlin
763days
Open House Original Discount Agreements 2024-10 – Tiotropium Bromide (Spiriva(R) Respimat, ATC: R03BB04)
Techniker Krankenkasse, HamburgTED 685248-2026
value not stated1 lot
Thu 30 Nov23:58 in Berlin
763days
Open-House-Originale Discount Agreements 2026-14 Crizotinib
Techniker Krankenkasse, HamburgTED 693690-2026
value not stated1 lot
Thu 30 Nov23:58 in Berlin
763days
Open-house discount contracts 2026-17 Tafamidis
Techniker Krankenkasse, HamburgTED 724203-2026
value not stated3 lots
Thu 30 Nov23:58 in Berlin
763days
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8, SGB V for the active substance Everolimus, ATC L04AH02 for the period 01.02.2026 - 31.01.2028 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 832234-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Desvenlafaxin, ATC N06AX23 for the period 01.02.2026 - 31.01.2028 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 830952-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Progesteron (excluding Dafo. WKA), ATC G03DA04 for the period 01.02.26 - 31.01.28 (including V.-option 1x12 months)
DAK-Gesundheit, HamburgTED 830300-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Prednisolone, ATC S01BA04 for the period 01.02.2026 - 31.01.2028 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 830981-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8, SGB V for the active substance Brimonidine + Timolol, ATC S01ED69 for the period 01.02.2026 - 31.01.2028 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 831825-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Apremilast, ATC L04AA32, for the period 01.02.2026 – 31.01.2028 (plus extension option 1x12 months)
DAK-Gesundheit, HamburgTED 829486-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8, SGB V for the active substance Brimonidine (excluding Dafo. EDP), ATC S01EA05 for the period 01.02.26 - 31.01.28 (including V.-option 1x12 months)
DAK-Gesundheit, HamburgTED 831596-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Betahistine, ATC N07CA01 for the period 01.02.26 - 31.01.28 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 831412-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance Adapalene + Benzoyl Peroxide, ATC D10AD23, for the period 01.02.2026 – 31.01.2028 (plus extension option 1x12 months)
DAK-Gesundheit, HamburgTED 829211-2025
€11 lot, 2 years
Tue 5 Dec12:00 in Berlin
768days
OpenHouse procedure for various pharmaceutical active substances from 01.10.2026
AOK Rheinland/Hamburg - Die Gesundheitskasse, DüsseldorfTED 367164-2026
value not stated1 lot, 2 years
Sun 31 Dec12:00 in Berlin
794days
Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 SGB V by way of an open-house model for the active ingredient Tiotropium bromide (ATC code according to WHO: R03BB04)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 705171-2026
value not stated1 lot
Sun 31 Dec23:58 in Berlin
794days
Open house biological discount agreements 2026-32 Aflibercept
Techniker Krankenkasse, HamburgTED 750455-2026
value not stated2 lots
Sun 31 Dec23:58 in Berlin
794days
Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 SGB V by way of an open-house model for the active ingredient Rotigotine (ATC code according to WHO: N04BC09), excluding packs larger than 84 units
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 707382-2026
value not stated1 lot
Sun 31 Dec23:58 in Berlin
794days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.